Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Renal Cell × Nelfinavir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma, Kaposi 3 Pancreatic Neoplasms 3 Neoplasms 3 Uterine Cervical Neoplasms 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sezary Syndrome 1 Sarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Prolymphocytic 1 Leukemia, Myeloid, Acute 1 Leukemia, Large Granular Lymphocytic 1 Leukemia 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 HIV Infections 1

Interventions

Sunitinib 72 Sorafenib 52 Everolimus 44 pazopanib 42 Nivolumab 42 Bevacizumab 39 pembrolizumab 31 aldesleukin 26 Interferon-alpha 26 temsirolimus 23 cabozantinib 19 Axitinib 19 Ipilimumab 16 Interleukin-2 15 Cyclophosphamide 15 fludarabine phosphate 13 Interferon alpha-2 13 Gemcitabine 13 Peripheral Blood Stem Cell Transplantation 10 Paclitaxel 10 Erlotinib Hydrochloride 10 Sirolimus 9 Docetaxel 8 Capecitabine 8 tremelimumab 7 lenvatinib 7 Radiosurgery 7 Fluorouracil 7 Fluorodeoxyglucose F18 7 Cyclosporine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01079286 2013-07-15

I-NET

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡